Vanishing bile duct syndrome associated with azithromycin in a 62-year-old man
- PMID: 19906050
- DOI: 10.1111/j.1742-7843.2009.00474.x
Vanishing bile duct syndrome associated with azithromycin in a 62-year-old man
Erratum in
- Basic Clin Pharmacol Toxicol. 2010 Aug;107(2):700. Danica, Juricic [corrected to Juricic, Danica]; Irena, Hrstic [corrected to Harstic, Irena]; Davor, Radic [corrected to Radic, Davor]; Mate, Skegro [corrected to Skegro, Mate]; Marijana, Coric [corrected to Coric, Marijana]; Boris, Vucelic [corrected to Vu
Abstract
Vanishing bile duct syndrome is a severe cholestatic disease associated with toxic effects of medications. Stevens-Johnson syndrome is a hypersensitivity disorder that may also be caused by medications. We present a case of a 62-year-old male patient who developed vanishing bile duct syndrome a month after Stevens-Johnson syndrome. These adverse drug reactions were associated with the use of azithromycin (500 mg daily for 3 days). The patient was initially treated for Stevens-Johnson syndrome with steroids, antihistamines and proton pump inhibitors and fully recovered. However, a month after the beginning of Stevens-Johnson syndrome, he developed vanishing bile duct syndrome and was treated with steroids, ursodeoxycholic acid, antihistamines and tacrolimus. Unfortunately, the treatment was unsuccessful and he was listed for liver transplantation which was performed 7 months after the beginning of jaundice. This is the first case of vanishing bile duct syndrome associated with the use of azithromycin and one of few that reports vanishing bile duct syndrome and Stevens-Johnson syndrome co-occurrence.
Similar articles
-
Acute vanishing bile duct syndrome after ibuprofen therapy in a child.J Pediatr. 2004 Aug;145(2):273-6. doi: 10.1016/j.jpeds.2004.05.027. J Pediatr. 2004. PMID: 15289784 Review.
-
Drug-associated acute-onset vanishing bile duct and Stevens-Johnson syndromes in a child.Gastroenterology. 1998 Sep;115(3):743-6. doi: 10.1016/s0016-5085(98)70154-4. Gastroenterology. 1998. PMID: 9721172
-
Stevens-Johnson syndrome as an unusual adverse effect of azithromycin.Acta Dermatovenerol Croat. 2006;14(1):40-5. Acta Dermatovenerol Croat. 2006. PMID: 16603101
-
Vanishing bile duct and Stevens-Johnson syndrome associated with ciprofloxacin treated with tacrolimus.World J Gastroenterol. 2008 Aug 7;14(29):4697-700. doi: 10.3748/wjg.14.4697. World J Gastroenterol. 2008. PMID: 18698687 Free PMC article.
-
Drug-induced vanishing bile duct syndrome: response to ursodiol.Am J Gastroenterol. 1996 Jul;91(7):1456-7. Am J Gastroenterol. 1996. PMID: 8678017 Review. No abstract available.
Cited by
-
Acute vanishing bile duct syndrome after therapy with cephalosporin, metronidazole, and clotrimazole: A case report.Medicine (Baltimore). 2017 Sep;96(36):e8009. doi: 10.1097/MD.0000000000008009. Medicine (Baltimore). 2017. PMID: 28885366 Free PMC article.
-
Drug associated vanishing bile duct syndrome combined with hemophagocytic lymphohistiocytosis.World J Gastrointest Endosc. 2012 Aug 16;4(8):376-8. doi: 10.4253/wjge.v4.i8.376. World J Gastrointest Endosc. 2012. PMID: 22912913 Free PMC article.
-
Structural and functional implications of the interaction between macrolide antibiotics and bile acids.Chemistry. 2015 Mar 9;21(11):4350-8. doi: 10.1002/chem.201406413. Epub 2015 Feb 5. Chemistry. 2015. PMID: 25655041 Free PMC article.
-
A case report of vanishing bile duct syndrome after exposure to pexidartinib (PLX3397) and paclitaxel.NPJ Breast Cancer. 2019 Jun 14;5:17. doi: 10.1038/s41523-019-0112-z. eCollection 2019. NPJ Breast Cancer. 2019. PMID: 31240240 Free PMC article.
-
Clinical and histologic features of azithromycin-induced liver injury.Clin Gastroenterol Hepatol. 2015 Feb;13(2):369-376.e3. doi: 10.1016/j.cgh.2014.07.054. Epub 2014 Aug 9. Clin Gastroenterol Hepatol. 2015. PMID: 25111234 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical